Barbara McGovern

The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

Jason Grebely, Kimberly Page, Rachel Sacks‐Davis et al. · Hepatology · 2013 · 396 citations · Full text

Life Sciences, Immunology, Infectious Diseases +12

A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent<i>Clostridium difficile</i>Infection

Sahil Khanna, Darrell S. Pardi, Colleen Kelly et al. · The Journal of Infectious Diseases · 2016 · 319 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1

Mark Sulkowski, Joseph J. Eron, David Wyles et al. · JAMA · 2015 · 305 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence

Julian Schulze zur Wiesch, Donatella Ciuffreda, Lia Laura Lewis‐Ximenez et al. · The Journal of Experimental Medicine · 2012 · 224 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

SER-109, an Investigational Microbiome Drug to Reduce Recurrence After <i>Clostridioides difficile</i> Infection: Lessons Learned From a Phase 2 Trial

Barbara McGovern, Christopher B. Ford, Matthew R. Henn et al. · Clinical Infectious Diseases · 2020 · 158 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13